HomeHOSPITALSDr. Joseph Ricotta Completes 200th TCAR Procedure at Delray Medical

Dr. Joseph Ricotta Completes 200th TCAR Procedure at Delray Medical

Joseph J. Ricotta, MD, MS, DFSVS, FACS,  National Medical Director for Vascular Surgery and Endovascular Therapy for Tenet Healthcare recently completed his 200th Transcarotid Artery Revascularization (TCAR) stroke prevention procedure at Delray Medical Center.

Dr. Joseph Ricotta was first in the State of Florida to perform the TCAR procedure in 2018. For patients diagnosed with carotid artery disease, the TCAR procedure is a minimally invasive approach compared with traditional surgical procedures such as carotid endarterectomy. The TCAR procedure is suited for patients who are at a higher risk of surgical complications due to age, medical co-morbidities, or anatomical issues.

In 2020, Dr. Ricotta received the national TCAR Clinical Operator of Experience distinction. Silk Road Medical, manufacturer of the TCAR device for patient procedures, awards select physicians throughout the country with this accolade who have demonstrated clinical excellence and superior quality outcomes using TCAR to treat patients with carotid artery disease.

“TCAR is a new treatment alternative for patients with carotid artery disease aimed to prevent a stroke. Carotid artery disease is the most common cause of stroke and usually occurs when plaque in the carotid artery breaks off and travels to the brain or impedes blood flow which can also cause a stroke,” said Dr. Ricotta.

During a TCAR procedure, Dr. Ricotta makes a small incision above the clavicle to access the carotid artery and insert a pliable sheath. The sheath links to a component temporarily reversing blood away from the brain in an effort to avert any plaque from traveling to the patient’s brain. With this reverse-flow neuroprotection in place, Dr. Ricotta performs balloon angioplasty and implants a stent inside of the carotid artery lesion to achieve long-term plaque stabilization and stroke prevention as well as open blood flow to the brain. Throughout the TCAR procedure, the blood filters removing any plaque or clot before returning to the body via an additional sheath in the femoral vein of the patient’s thigh. Once Dr. Ricotta places the stent in the artery to eliminate the plaque, the reversal flow mechanism switches and blood flows freely to the brain into its intended path free from stroke inducing plaque.

“If you compare TCAR to traditional carotid endarterectomy surgical treatment, TCAR carries a lower risk of stroke, heart attack, and death. TCAR is quicker than a traditional surgery with a shorter hospital stay (<24 hours) and less chance of bleeding, nerve injury, or re-intervention,” said Dr. Ricotta.

Dr. Ricotta performs the TCAR procedure in Delray Medical Center’s Endovascular Hybrid Operating Room Suite. At Dr. Ricotta’s Prime Vascular Institute medical practice in Delray Beach, a non-invasive Doppler ultrasound is available to diagnose a patient’s carotid artery disease.

Prime Vascular Institute is located at 4205 W. Atlantic Ave., Building B, Suite 201, Delray Beach, FL, 33445. For more information visit: PrimeVascular.com or call Dr. Ricotta’s office at 561-303-0013. In addition, Dr. Ricotta is on-staff at Delray Medical Center.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy